Xilio Therapeutics, Inc.
XLO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840233
No open-market purchases or sales by Xilio Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $32.6M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Xilio Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 34 | 1 | 31 | −2 |
| Shares | 16.4M | 249.6K | 12.5M | −3.71M (−22.9%) |
| Value | $9.03M | $137.3K | $13.5M | +$4.58M (+51.5%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Xilio Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 338,542 | $365.6K | 0.00% |
| SevenBridge Financial Group, LLC | 31,000 | $36.6K | 0.01% |
| PFG Investments, LLC | 30,000 | $32.4K | 0.00% |
| Prelude Capital Management, LLC | 29,500 | $31.9K | 0.00% |
| FNY Investment Advisers, LLC | 27,500 | $29.0K | 0.02% |
| Summit Trail Advisors, LLC | 16,000 | $17.3K | 0.00% |
Sold out (8)
Institutions that held Xilio Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Octagon Capital Advisors LP | 1,785,000 | $981.8K |
| Artal Group S.A. | 450,000 | $248.0K |
| Laurion Capital Management LP | 116,847 | $64.3K |
| ArrowMark Colorado Holdings LLC | 83,373 | $45.9K |
| Citadel Advisors LLC | 51,419 | $28.3K |
| Virtu Financial LLC | 10,763 | $6.00K |
| Cullen/Frost Bankers, Inc. | 100 | $55 |
| Bank of America Corp | 11 | $6 |
Not filed for Q1 2024 yet (1)
Institutions that held Xilio Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Trustees of Columbia University in the City of New York | 249,635 | $137.3K |